WASHINGTON--(BUSINESS WIRE)-- <\/p>\n
The Biotechnology Industry Organization (BIO) will unveil findings from a report on the role of Intellectual Property Rights (IPRs) in encouraging upstream R&D and downstream commercialization in biotechnology at the 2012 BIO International Convention in Boston, Mass. <\/p>\n
The report, titled Taking Stock: the Gains of Global Biotechnology Research from IPRs, will bring together experts to discuss how IPRs have affected innovation and the development of new biotechnologies and whether they contribute to growth in partnerships and other models of collaboration between biotechnology R&D actors such as universities, small and medium sized entities (SMEs) and pharmaceutical manufacturers. <\/p>\n
Rachel Chu, Senior Consultant, Pugatch Consilium <\/p>\n
About BIO <\/p>\n
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the worlds largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW,a multiblog platform and monthly newsletterthat aims to create an online biotech community where thethe industrycan connect to discuss the latest news. Subscribe to BIOtechNOW. <\/p>\n
For more information: Visit http:\/\/www.bio.org<\/a> Follow us on Twitter @IAmBiotech Join us on LinkedIn\/MyBio Become a fan at facebook.com\/IAmBiotech <\/p>\n<\/p>\n Link: WASHINGTON--(BUSINESS WIRE)-- The Biotechnology Industry Organization (BIO) will unveil findings from a report on the role of Intellectual Property Rights (IPRs) in encouraging upstream R&D and downstream commercialization in biotechnology at the 2012 BIO International Convention in Boston, Mass. The report, titled Taking Stock: the Gains of Global Biotechnology Research from IPRs, will bring together experts to discuss how IPRs have affected innovation and the development of new biotechnologies and whether they contribute to growth in partnerships and other models of collaboration between biotechnology R&D actors such as universities, small and medium sized entities (SMEs) and pharmaceutical manufacturers. Rachel Chu, Senior Consultant, Pugatch Consilium About BIO BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations Continue reading
\nBIO to Release Intellectual Property Rights Report at 2012 BIO International Convention<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"